Levy M - Search Results

1

Making inroads to precision medicine for the treatment of autoimmune diseases: Harnessing genomic studies to better diagnose and treat complex disorders.

Baglaenko Y, Wagner C, Bhoj VG, Brodin P, Gershwin ME, Graham D, Invernizzi P, Kidd KK, Korsunsky I, Levy M, Mammen AL, Nizet V, Ramirez-Valle F, Stites EC, Williams MS, Wilson M, Rose NR, Ladd V, Sirota M. Baglaenko Y, et al. Among authors: levy m. Camb Prism Precis Med. 2023 May 11;1:e25. doi: 10.1017/pcm.2023.14. eCollection 2023. Camb Prism Precis Med. 2023. PMID: 38550937 Free PMC article. Review.

2

Advances in the long-term treatment of neuromyelitis optica spectrum disorder.

Anderson M, Levy M. Anderson M, et al. Among authors: levy m. J Cent Nerv Syst Dis. 2024 Feb 1;16:11795735241231094. doi: 10.1177/11795735241231094. eCollection 2024. J Cent Nerv Syst Dis. 2024. PMID: 38312734 Free PMC article. Review.

3

Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice.

Wright AE, Nishiyama S, Han P, Kong P, Levy M. Wright AE, et al. Among authors: levy m. BMC Neurosci. 2024 Mar 11;25(1):16. doi: 10.1186/s12868-024-00859-y. BMC Neurosci. 2024. PMID: 38468222 Free PMC article.

4

Coeliac disease as a model for understanding multiple sclerosis.

Drosu N, Bjornevik K, Cortese M, Levy M, Sollid LM. Drosu N, et al. Among authors: levy m. Nat Rev Neurol. 2024 Nov;20(11):685-690. doi: 10.1038/s41582-024-01025-y. Epub 2024 Oct 8. Nat Rev Neurol. 2024. PMID: 39379493 Review.

5

The disease controversy and psychotherapy with alcoholics.

Levy MS. Levy MS. J Psychoactive Drugs. 1992 Jul-Sep;24(3):251-6. doi: 10.1080/02791072.1992.10471645. J Psychoactive Drugs. 1992. PMID: 1432403 Review.

6

Quantifying the economic burden to patients of relapse events from neuromyelitis optica spectrum disorders: A cross-sectional survey.

Rice DR, Holroyd KB, Pua DK, Levy M, Mateen FJ, Bhattacharyya S. Rice DR, et al. Among authors: levy m. Mult Scler Relat Disord. 2023 Mar;71:104580. doi: 10.1016/j.msard.2023.104580. Epub 2023 Feb 15. Mult Scler Relat Disord. 2023. PMID: 36805175

7

Radiologic and clinical stability in an HIV-negative MS patient after tenofovir: An updated case report.

Drosu N, Levy M. Drosu N, et al. Among authors: levy m. Mult Scler Relat Disord. 2024 Mar;83:105396. doi: 10.1016/j.msard.2023.105396. Epub 2024 Jan 13. Mult Scler Relat Disord. 2024. PMID: 38245999 No abstract available.

8

Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Molazadeh N, Bilodeau PA, Salky R, Bose G, Lotan I, Romanow G, Anderson MR, Matiello M, Chitnis T, Levy M. Molazadeh N, et al. Among authors: levy m. J Neurol Sci. 2024 Mar 15;458:122909. doi: 10.1016/j.jns.2024.122909. Epub 2024 Jan 30. J Neurol Sci. 2024. PMID: 38335710

9

Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes.

Manzano GS, Levy M, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Vasileiou ES, Sotirchos ES, Gibbons E, Huda S, Jacob A, Matiello M. Manzano GS, et al. Among authors: levy m. J Neurol. 2024 Sep;271(9):6160-6171. doi: 10.1007/s00415-024-12585-w. Epub 2024 Jul 27. J Neurol. 2024. PMID: 39066792

10

Individualized care for the treatment of alcoholism.

Levy MS. Levy MS. J Subst Abuse Treat. 1990;7(4):245-54. doi: 10.1016/0740-5472(90)90048-u. J Subst Abuse Treat. 1990. PMID: 2290187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,999 results

Search Page

Filters